Update on HSC

[Farkhairloss]

Has anyone been in contact with Histogen? Have they started there final trials in Japan as last mentioned? I tried to send them a email on there website but diesnt seem to go through.

[Swooping]

They are done.

[joachim]

histogen is dead.
it's only a matter of time until they admit it officially.

[Alias123]

In May 2015, Histogen opened an $18M Series D financing round. This round will provide capital for development of its HSC program, including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, other corporate purposes and to support preparation for an initial public offering (IPO).
why would it be dead?

[GSD]

its not dead,

the people here cry every time when 1-2 months are no news aviable ...

[hellouser]

In May 2015, Histogen opened an $18M Series D financing round. This round will provide capital for development of its HSC program, including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, other corporate purposes and to support preparation for an initial public offering (IPO).
why would it be dead?

They may not be dead, but their progress is pathetically slow.

[NeedHairASAP]

In May 2015, Histogen opened an $18M Series D financing round. This round will provide capital for development of its HSC program, including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, other corporate purposes and to support preparation for an initial public offering (IPO).
why would it be dead?

1. the average series D is around $50M.... and that's not even for bio-medical companies which should need more money than your average company raising a series D... $18M = nobody wants to give us any money so we'll take anything we can get.... series D is for losers who couldnt go public by their series C


2. why would they need money for a public offering? If they had something worth anything, they'd just do a public offering. "Hi we need $18M so that we can then go raise more money from the public".


3. They'd have found a partner if they had anything worth anything... unlike follicept, histogen has been around (as a relatively large formal business organization) for like a decade.... yet no partners...



Of course we don't know if they are dead.... but there isn't much going on in their favor as far as I can see...

we're talking about the company who said they'd be available in asia in 2012....

i.e. swipe your credit card and get injected.... It's now half-way through 2015 and they are about as far away from having people swipe a card and get injected in asia as they were in 2008...

This isn't "we need funding, we hypothetically think we have something and need to try it"... this is "we've tried this, and it wasn't great, so we need more money to try again"

[diffuseloser]

Its always female hair loss that seems to take priority anyway.

[hellouser]

Its always female hair loss that seems to take priority anyway.

Women's health takes a priority regardless. Feminists will never call that out as unfair though.... but if men do, they'll be labeled as misogynists.

[diffuseloser]

I'd have to agree with that. It truly is a woman's world nowadays. There's a fix for pretty much everything. If you're a man, you're shafted.